Geographic Atrophy Market to Witness Robust Growth by 2035 – BIS Research

What Is Geographic Atrophy? 

Geographic atrophy (GA) is an advanced form of age-related macular degeneration, characterized by the progressive loss of retinal cells, leading to irreversible vision loss in older adults. As a leading cause of blindness worldwide, GA significantly impacts patient quality of life and underscores the urgent need for advanced, accessible therapies and early intervention strategies. 

What Is the Market Outlook? 

Therapeutic Innovation: 

The market is witnessing robust progress in retinal therapies, with a particular focus on gene therapies, biologics, and stem cell treatments designed to slow or halt disease progression. 

Enhanced Diagnostics: 

Advancements in early detection—such as optical coherence tomography (OCT) and fundus imaging are enabling timely diagnosis and better clinical outcomes for patients. 

Rising Healthcare Investment: 

Growing healthcare expenditure and insurance coverage for vision-related conditions in regions with high AMD prevalence are broadening patient access to new therapies. 

How Fast Is the Market Growing? 

The geographic atrophy market is expected to maintain a strong growth trajectory from 2025 to 2035, driven by an increasing global burden of AMD, expanded treatment options, and improved healthcare infrastructure in both developed and emerging markets. 

How Will This Report Help You? 

Planning to Enter the Market? 

Evaluate opportunities in advanced retinal therapies, early diagnostic technologies, and patient management strategies worldwide. 

Analyzing the Competitive Landscape? 

Gain insights into the strategies of industry leaders such as F. Hoffmann-La Roche AG, Novartis AG, Apellis Pharmaceuticals Inc., and Astellas Pharma Inc. 

Seeking R&D Insights? 

Track advancements in biologics, gene therapies, and stem cell research aimed at geographic atrophy. 

Interested in Regional Market Trends? 

Understand how healthcare investment, prevalence of AMD, and access to treatment are shaping growth in key geographies. 

Download the Full TOC or Book a Preview  

What Technologies Are Transforming the Market? 

• Gene therapies targeting the underlying causes of retinal degeneration 
• Biologic drugs and monoclonal antibodies to slow GA progression 
• Stem cell-based regenerative approaches for retinal repair 
• Early detection technologies such as OCT and advanced fundus imaging 

What’s Driving Demand, Opportunities, and Barriers? 

Demand Drivers 

• Growing prevalence of AMD and vision impairment in the aging population 
• Rising investments in novel retinal therapies 
• Increased focus on early diagnosis and timely intervention 

Opportunities 

• Expansion of advanced therapies in both developed and emerging regions 
• Development of more accessible and affordable treatment options 
• Growth in insurance coverage for vision care 

Challenges 

• High costs associated with innovative therapies 
• Limited access in low-income and rural regions 
• Regulatory complexities and slow drug approvals 

Key Players 

• Apellis Pharmaceuticals Inc. 

• Astellas Pharma Inc. 

• Alkeus Pharmaceuticals Inc. 

• F. Hoffmann-La Roche AG 

• Novartis AG 

• Lineage Cell Therapeutics Inc. 

• Boehringer Ingelheim 

• 4D Molecular Therapeutics Inc. 

Strategic Developments 

• Intensive R&D in advanced biologic and gene therapies 
• Strategic partnerships and collaborations to accelerate therapy development 
• Investments aimed at enhancing patient access and improving treatment affordability 

Download the complete TOC now! 

Case Study 

The report features applications of novel biologic and gene therapies in managing GA, highlighting their impact on slowing disease progression, improving visual outcomes, and enhancing patient quality of life. Emphasis is placed on early detection techniques and the integration of personalized medicine in treatment protocols. 

Schedule a Call with Industry Experts  

Related Reports from BIS Research  

Nasal Polyposis Market 

Mucopolysaccharidosis Market 

Pleural Effusion Market 

About BIS Research  

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.    

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.     

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.    

Contact  

Head of Marketing   

Email: media@bisresearch.com     

BIS Research Inc.    

39111 PASEO PADRE PKWY STE 313,    

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights    

Get Expert Insights @https://community.insightmonk.com     

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research     

Connect with us on Twitter@ https://twitter.com/BISResearch    

Connect with us on Medium@ https://medium.com/@faisal.bis  

Connect with us on youtube@ https://www.youtube.com/@BISResearchInc